Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. QIAGEN N.V.
  6. News
  7. Summary
    QGEN   NL0012169213

QIAGEN N.V.

(QGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

QIAGEN NV : Deutsche Bank reiterates its Buy rating

05/04/2021 | 06:12am EDT

In a research note published by Falko Friedrichs, Deutsche Bank advises its customers to buy the stock.


ę MarketScreener with dpa-AFX Analyser 2021
All news about QIAGEN N.V.
05/07DGAP-PVRá : QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG ..
DJ
05/06QIAGEN Ná : Clinical Laboratory Tests Market To Demonstrate Massive Growth By 20..
AQ
05/06QIAGEN NVá : Buy rating from Deutsche Bank
MD
05/05QIAGEN NVá : Receives a Buy rating from Kepler Cheuvreux
MD
05/05QIAGEN Ná : And subsidiaries u.s. gaap quarterly report for the period ended mar..
PU
05/05QIAGEN Ná : Chief Financial Officer
PU
05/05DGAP-CMSá : QIAGEN N.V.: Release according to Article 50 of the WpHG [the German..
DJ
05/05QIAGEN N.V. : Release according to Article 50 of the WpHG [the German Securities..
EQ
05/04DGAP-PVRá : QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG ..
DJ
05/04QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German..
EQ
More news
Financials (USD)
Sales 2021 2 268 M - -
Net income 2021 482 M - -
Net Debt 2021 802 M - -
P/E ratio 2021 22,3x
Yield 2021 -
Capitalization 10 881 M 10 881 M -
EV / Sales 2021 5,15x
EV / Sales 2022 5,11x
Nbr of Employees 5 750
Free-Float 93,0%
Chart QIAGEN N.V.
Duration : Period :
QIAGEN N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QIAGEN N.V.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 58,33 $
Last Close Price 46,89 $
Spread / Highest target 53,6%
Spread / Average Target 24,4%
Spread / Lowest Target -12,6%
EPS Revisions
Managers and Directors
NameTitle
Thierry Bernard Chief Executive Officer & Managing Director
Roland Sackers Chief Financial Officer & Managing Director
Lawrence A. Rosen Chairman-Supervisory Board
Barthold Piening Senior Vice President & Head-Global Operations
Metin Colpan Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
QIAGEN N.V.-11.28%10 897
MODERNA, INC.56.17%65 346
LONZA GROUP AG1.51%47 533
IQVIA HOLDINGS INC.29.20%44 923
CELLTRION, INC.-25.77%32 687
SEAGEN INC.-22.39%25 314